Literature DB >> 21946542

Inter-examiner reproducibility of Ocular Response Analyzer using the waveform score quality index in healthy subjects.

Achilleas Mandalos1, Eleftherios Anastasopoulos, Leonidas Makris, Nikolaos Dervenis, Vasilis Kilintzis, Fotis Topouzis.   

Abstract

PURPOSE: To evaluate the inter-examiner reproducibility of Ocular Response Analyzer (ORA) parameters in healthy subjects using the waveform score (WS) for quality control of acquisition. PATIENTS AND METHODS: Fifteen healthy subjects had their intraocular pressure (IOP) measured with ORA by 2 masked examiners. An acquisition protocol that aimed at obtaining 4 reliable measurements in each eye with WS≥6 and with as few repeated measurements as possible was employed, whereas a maximum of 8 measurements per eye was allowed. Additional good quality criteria included symmetrical force-in and force-out applanation signal peaks on the ORA waveform and few or no distortions of the applanation signal curve. Only the right eyes were included in the analysis. Examiners were trained but not experienced. The inter-examiner reproducibility of ORA parameters was assessed using the intraclass correlation coefficient (ICC). Mean values of the best 4 measurements were considered in analysis.
RESULTS: ICC including the best 4 measurements per eye was high for all ORA parameters. Specifically, ICC for Goldmann-correlated IOP was 0.961, for corneal-compensated IOP was 0.962, for corneal resistance factor was 0.987, and for corneal hysteresis was 0.988. Similar reproducibility was found when only the 3 best measurements per eye were included in the analysis.
CONCLUSIONS: The protocol for IOP measurement with ORA using the WS ≥6 as quality index achieved high inter-examiner reproducibility for all ORA parameters. High reproducibility was obtained even by inexperienced examiners when considering the mean of the best 3 measurements per eye.

Entities:  

Mesh:

Year:  2013        PMID: 21946542     DOI: 10.1097/IJG.0b013e318227e63e1

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  8 in total

1.  Alterations in biomechanical properties of the cornea among patients with polycystic kidney disease.

Authors:  Kubra Serefoglu Cabuk; Bennur Esen; Kursat Atalay; Ahmet Kirgiz; Rukiye Aydin
Journal:  Int Ophthalmol       Date:  2017-06-29       Impact factor: 2.031

2.  Repeatability of Corneal Hysteresis Measurements in Glaucoma Patients During Routine Follow Up and After Cataract Surgery.

Authors:  Tzukit Zehavi-Dorin; Anne E Kutzscher; Mai Badr; Marta Mora; Yennie Shyu; Travis C Porco; Robert L Stamper
Journal:  J Glaucoma       Date:  2022-03-01       Impact factor: 2.290

Review 3.  Corneal hysteresis and its relevance to glaucoma.

Authors:  Madhvi Deol; David A Taylor; Nathan M Radcliffe
Journal:  Curr Opin Ophthalmol       Date:  2015-03       Impact factor: 3.761

4.  Association between long-term orthokeratology responses and corneal biomechanics.

Authors:  Andrew K C Lam; Ying Hon; Stanley Y Y Leung; Lu Shu-Ho; Jones Chong; David C C Lam
Journal:  Sci Rep       Date:  2019-08-29       Impact factor: 4.379

5.  Multiple scan averaging to yield accurate quantitative analysis of optical coherence tomography angiograms.

Authors:  Hafi M Khan; Alex Gentle; James A Armitage; Chi-Ho To; Andrew K C Lam
Journal:  Sci Rep       Date:  2020-04-10       Impact factor: 4.379

6.  Corneal Hysteresis in Thais and Variation of Corneal Hysteresis in Glaucoma.

Authors:  Kulawan Rojananuangnit
Journal:  Clin Optom (Auckl)       Date:  2021-10-01

7.  Corneal biomechanics in iatrogenic ectasia and keratoconus: A review of the literature.

Authors:  Majid Moshirfar; Jason N Edmonds; Nicholas L Behunin; Steven M Christiansen
Journal:  Oman J Ophthalmol       Date:  2013-01

8.  Corneal Biomechanical Properties of Keratoconic Eyes Following Penetrating Keratoplasty.

Authors:  Hamidu Gobeka; Özlem Barut Selver; Melis Palamar Onay; Sait Eğrilmez; Ayşe Yağcı
Journal:  Turk J Ophthalmol       Date:  2018-09-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.